Your browser doesn't support javascript.
loading
Is the information provided by amino acid PET radiopharmaceuticals clinically equivalent in gliomas?
Verger, A; Taieb, D; Guedj, E.
Affiliation
  • Verger A; Department of Nuclear Medicine, Assistance Publique-Hôpitaux de Marseille, Aix-Marseille Université, Timone University Hospital, Marseille, France. a.verger@chru-nancy.fr.
  • Taieb D; Department of Nuclear Medicine & Nancyclotep Imaging Platform, CHRU Nancy, Lorraine University, Nancy, France. a.verger@chru-nancy.fr.
  • Guedj E; IADI, INSERM, UMR 947, Lorraine University, Service de Médecine Nucléaire, rue du Morvan, 54500, Vandoeuvre-les, Nancy, France. a.verger@chru-nancy.fr.
Eur J Nucl Med Mol Imaging ; 44(8): 1408-1410, 2017 08.
Article in En | MEDLINE | ID: mdl-28451826
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiopharmaceuticals / Glioma Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Document type: Article Affiliation country: France
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiopharmaceuticals / Glioma Language: En Journal: Eur J Nucl Med Mol Imaging Journal subject: MEDICINA NUCLEAR Year: 2017 Document type: Article Affiliation country: France